Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
ACTIVE NOT RECRUITING
NCT02284919
PHASE1
[18F]ISO-1 Positron Emission Tomography (PET/CT) in Primary Breast Cancer
Sponsor: University of Pennsylvania
View on ClinicalTrials.gov
Summary
In this study, positron emission tomography (PET/CT) imaging will be used to evaluate sigma-2 (σ2) receptor activity in sites of primary breast cancer using the investigational radiotracer \[18F\]ISO-1.
Official title: Imaging of In Vivo Sigma-2 Receptor Expression With [18F]ISO-1 Positron Emission Tomography (PET/CT) in Primary Breast Cancer
Key Details
Gender
FEMALE
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
30
Start Date
2015-03-11
Completion Date
2026-11
Last Updated
2026-01-09
Healthy Volunteers
No
Conditions
Interventions
DRUG
[18F]ISO-1
\[18F\]ISO-1 PET/CT scan
Locations (1)
University of Pennsylvania Hospital
Philadelphia, Pennsylvania, United States